Complement C3 inhibition by compstatin decreased early fibrogenic events in sepsis-induced ARDS in baboons (242), suggesting that inhibiting complement could be a potential strategy for preventing pulmonary fibrosis in ARDS patients. This evidence concerns the gene C3 and Sepsis.